Loading
Insider filings for Aralez Pharmaceuticals Inc. are scarce in the SEC (Form 4) feed, the latest one published on 9 February 2016. This page will fill in as new trades are disclosed. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
FY ended December 2017 · cache
16 of 16 declarations
Aralez Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of therapeutic products. It is listed on NASDAQ under the ticker ARLZ.